Aberdeen Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128M | Sell |
287,967
-16,747
| -5% | -$7.46M | 0.22% | 92 |
|
|
2025
Q1 | $147M | Sell |
304,714
-42,856
| -12% | -$20.7M | 0.29% | 68 |
|
|
2024
Q4 | $139M | Sell |
347,570
-23,519
| -6% | -$9.43M | 0.26% | 77 |
|
|
2024
Q3 | $173M | Sell |
371,089
-313
| -0.1% | -$146K | 0.32% | 63 |
|
|
2024
Q2 | $174M | Sell |
371,402
-202,795
| -35% | -$95.1M | 0.33% | 58 |
|
|
2024
Q1 | $240M | Sell |
574,197
-6,821
| -1% | -$2.85M | 0.47% | 37 |
|
|
2023
Q4 | $236M | Buy |
581,018
+384,730
| +196% | +$157M | 0.51% | 32 |
|
|
2023
Q3 | $68.3M | Sell |
196,288
-837
| -0.4% | -$291K | 0.17% | 120 |
|
|
2023
Q2 | $69.4M | Sell |
197,125
-1,760
| -0.9% | -$619K | 0.16% | 127 |
|
|
2023
Q1 | $62.7M | Buy |
198,885
+15,069
| +8% | +$4.75M | 0.16% | 134 |
|
|
2022
Q4 | $53.1M | Sell |
183,816
-2,999
| -2% | -$866K | 0.14% | 153 |
|
|
2022
Q3 | $54.1M | Buy |
186,815
+80,841
| +76% | +$23.4M | 0.16% | 132 |
|
|
2022
Q2 | $29.8M | Buy |
105,974
+9,591
| +10% | +$2.7M | 0.09% | 230 |
|
|
2022
Q1 | $25.1M | Buy |
96,383
+1,760
| +2% | +$458K | 0.06% | 271 |
|
|
2021
Q4 | $20.8M | Sell |
94,623
-420,216
| -82% | -$92.3M | 0.05% | 333 |
|
|
2021
Q3 | $94.3M | Sell |
514,839
-12,600
| -2% | -$2.31M | 0.21% | 111 |
|
|
2021
Q2 | $106M | Buy |
527,439
+430,311
| +443% | +$86.8M | 0.23% | 93 |
|
|
2021
Q1 | $20.9M | Buy |
97,128
+6,845
| +8% | +$1.47M | 0.05% | 336 |
|
|
2020
Q4 | $21.3M | Buy |
90,283
+3,165
| +4% | +$748K | 0.05% | 305 |
|
|
2020
Q3 | $23.7M | Sell |
87,118
-12,406
| -12% | -$3.38M | 0.06% | 257 |
|
|
2020
Q2 | $28.9M | Sell |
99,524
-1,549
| -2% | -$450K | 0.08% | 227 |
|
|
2020
Q1 | $24.1M | Sell |
101,073
-24,504
| -20% | -$5.83M | 0.08% | 222 |
|
|
2019
Q4 | $27.5M | Sell |
125,577
-1,876
| -1% | -$411K | 0.07% | 269 |
|
|
2019
Q3 | $21.6M | Sell |
127,453
-54,111
| -30% | -$9.17M | 0.05% | 314 |
|
|
2019
Q2 | $33.3M | Sell |
181,564
-108,875
| -37% | -$20M | 0.07% | 259 |
|
|
2019
Q1 | $53.4M | Sell |
290,439
-431,610
| -60% | -$79.4M | 0.12% | 157 |
|
|
2018
Q4 | $117M | Sell |
722,049
-164,557
| -19% | -$26.7M | 0.28% | 87 |
|
|
2018
Q3 | $171M | Sell |
886,606
-258,307
| -23% | -$49.8M | 0.32% | 80 |
|
|
2018
Q2 | $195M | Buy |
1,144,913
+807,086
| +239% | +$137M | 0.37% | 67 |
|
|
2018
Q1 | $55.1M | Buy |
337,827
+170,495
| +102% | +$27.8M | 0.11% | 185 |
|
|
2017
Q4 | $25.1M | Buy |
167,332
+95,825
| +134% | +$14.4M | 0.05% | 315 |
|
|
2017
Q3 | $10.9M | Buy |
+71,507
| New | +$10.9M | 0.02% | 437 |
|